ARCHIVES

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

This article is from The Cancer Letter archive.

Vol. 16 No. 31 | August 3, 1990

Download PDF Visit The Full Archive

Related Articles

On Capitol Hill: Funding Outlook Brighter For NIH and NCI as appropriators Provide Increases

October 1, 1999

DCPC Advisors OK PA On cancer Control In Disadvantaged

June 14, 1991

NCAB Rejects Automatic Loss Of Comprehensive Status For Center Without Core Grants

September 29, 1978

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

December 28, 2012

High-Starch Diet May Raise Risk Of Pancreatic Cancer

October 25, 2002

Mayo Clinic’s NCI Designation Extended To Arizona, Florida Sites

July 26, 2002